Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

Basit Öğe Kaydı
dc.contributor.authorSakin, Yusuf Serdar
dc.contributor.authorPolat, Zülfikar
dc.contributor.authorDemirci, Hakan
dc.contributor.authorKekilli, Murat
dc.contributor.authorUygun, Ahmet
dc.contributor.authorBağcı, Sait
dc.date.accessioned2019-05-13T09:03:46Z
dc.date.available2019-05-13T09:03:46Z
dc.date.issued2014
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractDear Editor, We read with great interest the recently published article by Fukuda et al. 1 The authors indicate that there is significant correlation between serum telaprevir (TVR) level and bodyweight and suggest that adjustment of TVR dose according to bodyweight would avoid renal impairment during treatment. Herein, we want to present a case in which renal impairment completely reversed after discontinuation of TVR, and ribavirin dose reduction seemed to be important in improving renal impairment until therapy.
dc.identifier.citationSakin, Y. S., Polat, Z., Demirci, H., Kekilli, M., Uygun, A., Bağcı, S. (2014). Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C. Hepatology Research, 44(9), 1037-1037.
dc.identifier.doi10.1111/hepr.12278
dc.identifier.endpage1037en_US
dc.identifier.issn1386-6346
dc.identifier.issue9en_US
dc.identifier.scopusqualityQ1
dc.identifier.startpage1037en_US
dc.identifier.urihttps://doi.org/10.1111/hepr.12278
dc.identifier.urihttps://hdl.handle.net/11491/1532
dc.identifier.volume44en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.relation.ispartofHepatology Research
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject[Belirlenecek]en_US
dc.titleReply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
dc.typeOther

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu